zepbound thyroid cancer - HEALTHIES
Quick Answer: No confirmed cases of cancer directly caused by Zepbound have been reported in human clinical trials or post-marketing surveillance to date. Zepbound carries an FDA boxed warning for thyroid C-cell tumors based on rodent studies, though human relevance remains uncertain. Does Using GLP-1 Drugs, Like Zepbound or Wegovy, Increase Your Risk of Thyroid Cancer?
Understanding the Context
CU Cancer Center member Bryan Haugen, MD, breaks down the science behind the FDA warning on the popular weight-loss medications. As of 2024, there are no confirmed cases of thyroid cancer directly attributed to Zepbound in humans. However, the FDA states that it is unknown whether Zepbound causes thyroid C-cell tumors, including MTC, in humans. There is no evidence that Zepbound (tirzepatide) causes thyroid cancer in humans, and no percentage can be provided because this association does not exist in clinical data.
Image Gallery
Key Insights
Does Zepbound Cause Thyroid Cancer? Zepbound does not have a proven causal link to thyroid cancer in humans, though it carries an FDA boxed warning based on animal studies. Despite research indicating an increased risk of thyroid tumors in animal models, there has been no definitive evidence proving a causal link between ZEPBOUND and thyroid cancer in humans. People who are good candidates for weight loss medications often have health risks that are greater than the low risk of thyroid cancer. Nonetheless, this is an important risk/benefit discussion for people to have with their doctor.
Related Articles You Might Like:
what is hdl cholesterol in blood test how many wisdom teeth do people have best coffee creamer weight watchersFinal Thoughts
We probably should be cautious about using them in patients with familial thyroid cancer and those with a ge-netic predisposition for papillary or follicular thyroid cancer. Q: Should we be concerned about thyroid cancer in patients taking ... A 2026 Clayman Thyroid Center white paper reviews the latest evidence on GLP-1 drugs like Ozempic and Mounjaro and thyroid cancer risk. Current data shows no convincing link to common thyroid cancers. The current U.S. prescribing information for both Mounjaro and Zepbound states that it is not known whether tirzepatide causes thyroid C‑cell tumors, including MTC, in humans, but recommends counseling patients about neck masses, trouble speaking, difficulty breathing, and persistent hoarseness.